Listed

Black Diamond Therapeutics, Inc.: Form 10-Q for the period ended Jun 30, 2021

Filed with the SEC on Aug 12, 2021 and accepted by EDGAR at Aug 12, 2021, 08:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development3 months2021-04-01 to 2021-06-30$26.7mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2021-01-01 to 2021-06-30$49.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2021-04-01 to 2021-06-30−$34.7mus-gaap:OperatingIncomeLoss
Operating income6 months2021-01-01 to 2021-06-30−$65.4mus-gaap:OperatingIncomeLoss
Interest expense6 months2021-01-01 to 2021-06-30$0us-gaap:InterestExpense
Net income3 months2021-04-01 to 2021-06-30−$34.4mus-gaap:NetIncomeLoss
Net income6 months2021-01-01 to 2021-06-30−$64.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2021-04-01 to 2021-06-30−$0.95us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2021-01-01 to 2021-06-30−$1.79us-gaap:EarningsPerShareDiluted
Basic EPS3 months2021-04-01 to 2021-06-30−$0.95us-gaap:EarningsPerShareBasic
Basic EPS6 months2021-01-01 to 2021-06-30−$1.79us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2021-04-01 to 2021-06-3036,182,541 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2021-01-01 to 2021-06-3036,152,942 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2021-01-01 to 2021-06-30−$49.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2021-01-01 to 2021-06-30$888.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-06-30$37.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-06-30$270.9mus-gaap:AssetsCurrent
Total assetsAt period end2021-06-30$287.9mus-gaap:Assets
Current liabilitiesAt period end2021-06-30$23.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-06-30$36.9mus-gaap:Liabilities
Shareholders' equityAt period end2021-06-30$251.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001701541-21-000034. Last ingested by Listed: Nov 10, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.